The Medicine Accelerator Expands Digital Business Unit, Opens Key Leadership and Product Roles

iAchieve®—the industry’s most advanced digital CMC platform, built on 100,000s of expert-led experiments and thousands of contextualized programs—enters next phase of global scale-up.

The Medicine Accelerator today announced a major strategic expansion of its digital business, opening a series of high-impact roles that will shape the future of how medicines are developed, manufactured, and brought to market. The expansion reflects the organization's commitment to embedding digital and AI capabilities at the core of its Chemistry, Manufacturing, and Controls (CMC) offering.

Despite years of effort, digital transformation in the pharmaceutical sector remains fragmented. Data is plentiful but underleveraged. AI is promising but often disconnected from real-world development workflows. And while most biopharma companies have declared digital ambitions, few have demonstrated scalable, operational impact.

The Medicine Accelerator is changing that—starting with iAchieve®.

iAchieve®, first launched in 2021, was the industry’s first digital CMC ecosystem. It brought together live R&D and manufacturing data, scientific knowledge, and regulatory wisdom into a single, CMC command center. Today, it sits atop an unmatched foundation:

• Thousands of contextualized CMC programs across modalities

• Hundreds of thousands of expert-run experiments, digitally captured

• A social network of scientific decision-making, enabling knowledge reuse, insight propagation, and regulatory continuity

Now in its next phase, iAchieve® has become an agentic, intelligent engine—one that doesn’t just organize information, but curates it, contextualizes it, and activates it to accelerate decision-making and reduce time-to-market.

To lead this evolution, The Medicine Accelerator is launching a Digital Business Unit and actively hiring for several strategic roles, including:

• Managing Director / COO – Digital Business Unit (iAchieve®)

• Product Manager – Digital Platform Implementation

“Our goal is to build the global standard for digital-led CMC transformation.,” said Dr. Mark Barrett, CEO of The Medicine Accelerator. “To do that, we need visionary leaders who understand the science, value the data, and can operationalize both at speed.”

The expanded digital unit will operate alongside APC and VLE Therapeutics under The Medicine Accelerator umbrella, with full commercial, product, and execution responsibility. The team will be charged with advancing iAchieve's roadmap, developing new data services, and building a customer-centric engine that helps biopharma partners—eight of the top ten among them—accelerate innovation.

Interested candidates can learn more and apply at: https://approcess.com/careers

About The Medicine Accelerator
The Medicine Accelerator—comprising APC, VLE Therapeutics, and iAchieve—partners with leading pharmaceutical and biotech companies to radically improve how medicines are developed and manufactured. Through integrated R&D, GMP manufacturing, and now digital transformation, The Medicine Accelerator enables speed to patients without compromising scientific depth.